Serial Number | 88294201 |
Word Mark | G |
Filing Date | Friday, February 8, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 9, 2024 |
Registration Number | 7265524 |
Registration Date | Tuesday, January 9, 2024 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, October 24, 2023 |
Goods and Services | Providing online non-downloadable audio and video recordings containing information in the field of medical testing services, namely, genetic testing and genetic screening over a global computer network |
Description of Mark | The mark consists of a stylized, rounded lower case "G" having a tilted teardrop-shaped upper portion and floating, curved lower portion. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Advertising the goods and services of others focused on the application of personal genetic information for pain management, mental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain management, mental health and other comorbid conditions, and marketing services, namely, marketing consultancy for businesses in the field of personal genetic information for pain management, mental health and other comorbid conditions, all the foregoing not including veterinary or plant applications |
Goods and Services | Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing services, namely, personalized medical tests based on the assessment, development and application of human genomic discoveries in the medical industry; online medical testing services, namely, genetic testing and genetic screening; Medical information services, namely, providing personalized information online in the field of genetic testing for medical purposes; medical information services, namely, reporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, personal genetic information for pain management, mental health and other comorbid conditions and for understanding individual responses to medication, all the foregoing not including veterinary or plant applications; medical information services, namely, analyzing pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications; medical information services, namely, preparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, analyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticals, all the foregoing not including veterinary or plant applications |
Goods and Services | Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatments, pharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing services, namely, pharmacogenetic tests, gene sequencing-based tests and genotyping based on the assessment, development and application of human genomic discoveries in the pharmaceutical, informatics and human clinical diagnostic industries, all the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing services, namely, platform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain management, mental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing services, namely, providing genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, August 3, 2019 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 28, 2019 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, August 3, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, March 2, 2019 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Inagene Diagnostics Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Toronto M4P2E5 CA |
Party Name | Inagene Diagnostics Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Toronto M4P2E5 CA |
Party Name | Inagene Diagnostics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Toronto M4P2E5 CA |
Event Date | Event Description |
Tuesday, January 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, January 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, October 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 24, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, October 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, September 18, 2023 | ELECTRONIC RECORD REVIEW COMPLETE |
Friday, September 15, 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Friday, September 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, September 7, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, September 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, September 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, June 6, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Tuesday, June 6, 2023 | PRIORITY ACTION E-MAILED |
Tuesday, June 6, 2023 | PRIORITY ACTION WRITTEN |
Wednesday, February 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, February 15, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, February 14, 2023 | ASSIGNED TO LIE |
Monday, February 6, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Saturday, August 6, 2022 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Saturday, August 6, 2022 | INQUIRY TO SUSPENSION E-MAILED |
Saturday, August 6, 2022 | SUSPENSION INQUIRY WRITTEN |
Thursday, July 7, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Monday, March 7, 2022 | ASSIGNED TO EXAMINER |
Thursday, December 16, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, December 16, 2021 | LETTER OF SUSPENSION E-MAILED |
Thursday, December 16, 2021 | SUSPENSION LETTER WRITTEN |
Thursday, June 10, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, June 10, 2021 | LETTER OF SUSPENSION E-MAILED |
Thursday, June 10, 2021 | SUSPENSION LETTER WRITTEN |
Thursday, December 10, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, December 10, 2020 | LETTER OF SUSPENSION E-MAILED |
Thursday, December 10, 2020 | SUSPENSION LETTER WRITTEN |
Thursday, December 10, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 10, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 2, 2020 | ASSIGNED TO LIE |
Monday, November 2, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Friday, May 1, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Friday, May 1, 2020 | INQUIRY TO SUSPENSION E-MAILED |
Friday, May 1, 2020 | SUSPENSION INQUIRY WRITTEN |
Friday, November 1, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, November 1, 2019 | LETTER OF SUSPENSION E-MAILED |
Friday, November 1, 2019 | SUSPENSION LETTER WRITTEN |
Monday, October 28, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, October 28, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, October 23, 2019 | ASSIGNED TO LIE |
Thursday, October 17, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, September 24, 2019 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Tuesday, September 24, 2019 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Tuesday, September 24, 2019 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
Tuesday, September 24, 2019 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Saturday, August 3, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, August 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, August 2, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, March 25, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, March 25, 2019 | NON-FINAL ACTION E-MAILED |
Monday, March 25, 2019 | NON-FINAL ACTION WRITTEN |
Monday, March 25, 2019 | ASSIGNED TO EXAMINER |
Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Saturday, March 2, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 12, 2019 | NEW APPLICATION ENTERED |